ORPHENGESIC FORTE 770 mg/1
Orphenadrine Citrate, Aspirin and Caffeine · TABLET · Galt Pharmaceuticals, LLC
No Recall History
Plain English
ORPHENGESIC FORTE is a tablet containing orphenadrine citrate, aspirin and caffeine at 770 mg/1, taken oral. Manufactured by Galt Pharmaceuticals, LLC.
Key Facts
- Brand Name
- ORPHENGESIC FORTE
- Generic Name
- Orphenadrine Citrate, Aspirin and Caffeine
- NDC Code (Product)
61825-302- Manufacturer
- Galt Pharmaceuticals, LLC
- Strength
- 770 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- ANDA075141
- Drug Class
- Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]
- Marketing Start
- 06/08/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is ORPHENGESIC FORTE used for?
ORPHENGESIC FORTE contains Orphenadrine Citrate, Aspirin and Caffeine. It is a tablet taken oral. Consult your doctor for specific uses.
Is ORPHENGESIC FORTE a controlled substance?
ORPHENGESIC FORTE is not classified as a controlled substance by the DEA.
What is the generic name for ORPHENGESIC FORTE?
The generic name for ORPHENGESIC FORTE is Orphenadrine Citrate, Aspirin and Caffeine. There are 4 other brand versions of Orphenadrine Citrate, Aspirin and Caffeine.
What is the NDC code for ORPHENGESIC FORTE 770 mg/1?
The NDC (National Drug Code) for ORPHENGESIC FORTE 770 mg/1 is 61825-302, listed by Galt Pharmaceuticals, LLC.